Literature DB >> 12222823

Content and localization of myostatin in mouse skeletal muscles during aging, mechanical unloading and reloading.

S Kawada1, C Tachi, N Ishii.   

Abstract

Changes in myostatin content and localization in mouse skeletal muscles were investigated during aging, hindlimb suspension (HS) and reloading after HS. During aging, the content of myostatin among solubilized proteins in gastrocnemius and plantaris muscles (Gast/Plant) was initially low and increased until their wet weight/body weight ratio reached a peak. It remained unchanged with further aging, although gradual atrophy of the muscles was seen to occur. Also, the myostatin content did not change significantly during HS (up to 14 days) in both Gast/Plant and soleus muscles, though the muscles showed morphological signs of atrophy. However, reloading for 2 days after a 14-day HS caused significant decreases in the myostatin content in both of these muscles. Immunohistochemical observations showed the sarcoplasmic existence of myostatin, the amount of which appeared to decrease after reloading. The results suggest that myostatin plays a part in the processes of muscular growth and loading-induced hypertrophy, but is not involved in either aging-related or unloading-induced muscular atrophy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12222823     DOI: 10.1023/a:1016366409691

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  28 in total

1.  Modulation of myostatin expression during modified muscle use.

Authors:  M Wehling; B Cai; J G Tidball
Journal:  FASEB J       Date:  2000-01       Impact factor: 5.191

2.  A Smad transcriptional corepressor.

Authors:  D Wotton; R S Lo; S Lee; J Massagué
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

3.  Differential adaptation of growth and differentiation factor 8/myostatin, fibroblast growth factor 6 and leukemia inhibitory factor in overloaded, regenerating and denervated rat muscles.

Authors:  K Sakuma; K Watanabe; M Sano; I Uramoto; T Totsuka
Journal:  Biochim Biophys Acta       Date:  2000-06-02

4.  Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression.

Authors:  J R Florini; D Z Ewton; S L Roof
Journal:  Mol Endocrinol       Date:  1991-05

5.  Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function.

Authors:  E R Barton-Davis; D I Shoturma; A Musaro; N Rosenthal; H L Sweeney
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

6.  Satellite cell proliferation and increase in the number of myonuclei induced by testosterone in the levator ani muscle of the adult female rat.

Authors:  Y Joubert; C Tobin
Journal:  Dev Biol       Date:  1989-02       Impact factor: 3.582

7.  c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.

Authors:  S Akiyoshi; H Inoue; J Hanai; K Kusanagi; N Nemoto; K Miyazono; M Kawabata
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

8.  Characterization and determination of the biological activities of noncleavable high molecular weight forms of inhibin A and activin A.

Authors:  A J Mason; P G Farnworth; J Sullivan
Journal:  Mol Endocrinol       Date:  1996-09

9.  Myostatin regulation during skeletal muscle regeneration.

Authors:  S Kirk; J Oldham; R Kambadur; M Sharma; P Dobbie; J Bass
Journal:  J Cell Physiol       Date:  2000-09       Impact factor: 6.384

10.  An E box in the desmin promoter cooperates with the E box and MEF-2 sites of a distal enhancer to direct muscle-specific transcription.

Authors:  H Li; Y Capetanaki
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

View more
  18 in total

1.  Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle.

Authors:  Eric J Stevenson; Paul G Giresi; Alan Koncarevic; Susan C Kandarian
Journal:  J Physiol       Date:  2003-07-04       Impact factor: 5.182

2.  A modified enrichment protocol for adult caprine skeletal muscle stem cell.

Authors:  Ajai K Tripathi; Umed V Ramani; Viral B Ahir; Dharamshi N Rank; Chaitanya G Joshi
Journal:  Cytotechnology       Date:  2010-09-24       Impact factor: 2.058

3.  Fighting obesity: When muscle meets fat.

Authors:  Xin Yang; Pengpeng Bi; Shihuan Kuang
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

4.  Changes in Lean Mass and Serum Myostatin with Habitual Protein Intake and High-Velocity Resistance Training.

Authors:  A Binns; M Gray; A C Henson; I L Fort
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

5.  Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice.

Authors:  Raouia Fakhfakh; Annick Michaud; Jacques P Tremblay
Journal:  Mol Ther       Date:  2010-08-10       Impact factor: 11.454

Review 6.  Murine models of atrophy, cachexia, and sarcopenia in skeletal muscle.

Authors:  Mark Romanick; Ladora V Thompson; Holly M Brown-Borg
Journal:  Biochim Biophys Acta       Date:  2013-03-20

Review 7.  Effect of aging on cellular mechanotransduction.

Authors:  Miaozong Wu; Jacqueline Fannin; Kevin M Rice; Bin Wang; Eric R Blough
Journal:  Ageing Res Rev       Date:  2009-11-20       Impact factor: 10.895

8.  Association of the K153R polymorphism in the myostatin gene and extreme longevity.

Authors:  Nuria Garatachea; Tomàs Pinós; Yolanda Cámara; Gabriel Rodríguez-Romo; Enzo Emanuele; Giovanni Ricevuti; Letizia Venturini; Alejandro Santos-Lozano; Catalina Santiago-Dorrego; Carmen Fiuza-Luces; Thomas Yvert; Antoni L Andreu; Alejandro Lucia
Journal:  Age (Dordr)       Date:  2013-01-25

Review 9.  Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways.

Authors:  J Rodriguez; B Vernus; I Chelh; I Cassar-Malek; J C Gabillard; A Hadj Sassi; I Seiliez; B Picard; A Bonnieu
Journal:  Cell Mol Life Sci       Date:  2014-07-31       Impact factor: 9.261

Review 10.  Sarcopenia: etiology, clinical consequences, intervention, and assessment.

Authors:  T Lang; T Streeper; P Cawthon; K Baldwin; D R Taaffe; T B Harris
Journal:  Osteoporos Int       Date:  2009-09-25       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.